Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro-Reference-Cited by-同舟云学术

Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro

Published:2018-07-18 Issue:3 Volume:37 Page:415-423
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Weinreich Jürgen,Struller Florian,Sautkin Iaroslav,Giuashvili Shalva,Reymond Marc,Königsrainer Alfred,Schott Timm C.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-018-0641-6.pdf

Reference33 articles.

1. Lambert LA (2015) Looking up: recent advances in understanding and treating peritoneal carcinomatosis. CA Cancer J Clin 65(4):284–298. https://doi.org/10.3322/caac.21277

2. Franko J, Shi Q, Meyers JP, Maughan TS, Adams RA, Seymour MT, Saltz L, Punt CJA, Koopman M, Tournigand C, Tebbutt NC, Diaz-Rubio E, Souglakos J, Falcone A, Chibaudel B, Heinemann V, Moen J, De Gramont A, Sargent DJ, Grothey A, Analysis, research in cancers of the digestive system G (2016) Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol 17(12):1709–1719. https://doi.org/10.1016/S1470-2045(16)30500-9

3. Ceelen WP, Flessner MF (2010) Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. Nat Rev Clin Oncol 7(2):108–115. https://doi.org/10.1038/nrclinonc.2009.217

4. Jiang Y, Fan H, Jiang Y, Song G, Wang F, Li X, Li G (2017) Efficacy and safety of FOLFIRI and biotherapy versus FOLFIRI alone for metastatic colorectal cancer patients: a meta-analysis. Medicine (Baltimore) 96(48):e8767. https://doi.org/10.1097/MD.0000000000008767

5. Ji WB, Hong KD, Kim JS, Joung SY, Um JW, Min BW (2018) Effect of a shortened duration of FOLFOX chemotherapy on the survival rate of patients with stage II and III colon cancer. Chemotherapy 63(1):8–12. https://doi.org/10.1159/000481566

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens;Pleura and Peritoneum;2024-02-28

2. Amplifying Curcumin’s Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment;OncoTargets and Therapy;2024-01

3. HIPEC and PIPAC for gastric cancer: technique and comparison of efficacy. Literature review;Malignant tumours;2023-09-04

4. Pressurized intraperitoneal aerosol chemotherapy (PIPAC): updated systematic review using the IDEAL framework;British Journal of Surgery;2022-09-03

5. Review of Regional Therapies for Gastric Cancer with Peritoneal Metastases;Cancers;2022-01-23